Rank | Gene Set | Z-score |
---|---|---|
1 | cellular extravasation (GO:0045123) | 6.47724531 |
2 | microglial cell activation (GO:0001774) | 5.39090385 |
3 | positive regulation of chemokine biosynthetic process (GO:0045080) | 5.32775495 |
4 | regulation of MHC class II biosynthetic process (GO:0045346) | 5.12895169 |
5 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 4.90940841 |
6 | regulation of chemokine biosynthetic process (GO:0045073) | 4.77366536 |
7 | positive regulation of histone deacetylation (GO:0031065) | 4.70595415 |
8 | reactive oxygen species biosynthetic process (GO:1903409) | 4.62870217 |
9 | negative regulation of interleukin-12 production (GO:0032695) | 4.43309914 |
10 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.32649920 |
11 | purine deoxyribonucleotide catabolic process (GO:0009155) | 4.21660699 |
12 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 4.21657658 |
13 | regulation of growth of symbiont in host (GO:0044126) | 4.07930158 |
14 | negative regulation of growth of symbiont in host (GO:0044130) | 4.07930158 |
15 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 4.07930158 |
16 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 4.07930158 |
17 | neutrophil activation involved in immune response (GO:0002283) | 4.01546644 |
18 | macrophage activation (GO:0042116) | 3.98854849 |
19 | neutrophil mediated immunity (GO:0002446) | 3.93860049 |
20 | positive regulation of protein deacetylation (GO:0090312) | 3.85861107 |
21 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.83165794 |
22 | formation of translation preinitiation complex (GO:0001731) | 3.81817098 |
23 | macrophage chemotaxis (GO:0048246) | 3.71699818 |
24 | proteasome assembly (GO:0043248) | 3.71517842 |
25 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.71461922 |
26 | purine nucleobase biosynthetic process (GO:0009113) | 3.67038136 |
27 | negative regulation of phagocytosis (GO:0050765) | 3.55226453 |
28 | nucleobase biosynthetic process (GO:0046112) | 3.50575285 |
29 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.50474282 |
30 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.43842804 |
31 | phagosome maturation (GO:0090382) | 3.39096493 |
32 | positive regulation of antigen processing and presentation (GO:0002579) | 3.37082132 |
33 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.36273658 |
34 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.36273658 |
35 | modulation by symbiont of host immune response (GO:0052553) | 3.36273658 |
36 | positive regulation by symbiont of host defense response (GO:0052509) | 3.36273658 |
37 | modulation by symbiont of host defense response (GO:0052031) | 3.36273658 |
38 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.36273658 |
39 | immunoglobulin mediated immune response (GO:0016064) | 3.34448765 |
40 | negative regulation of interleukin-2 production (GO:0032703) | 3.29974329 |
41 | folic acid transport (GO:0015884) | 3.29797243 |
42 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.29581947 |
43 | regulation of mast cell degranulation (GO:0043304) | 3.28770386 |
44 | negative regulation of cell killing (GO:0031342) | 3.27794453 |
45 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.27794453 |
46 | ribosome assembly (GO:0042255) | 3.27644695 |
47 | * amino sugar catabolic process (GO:0046348) | 3.26375479 |
48 | myeloid leukocyte mediated immunity (GO:0002444) | 3.25352494 |
49 | positive regulation of mast cell activation (GO:0033005) | 3.24978216 |
50 | myeloid dendritic cell differentiation (GO:0043011) | 3.21966971 |
51 | natural killer cell mediated immunity (GO:0002228) | 3.21589400 |
52 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.21589400 |
53 | positive regulation of mast cell degranulation (GO:0043306) | 3.21461958 |
54 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.21461958 |
55 | positive regulation of interferon-alpha production (GO:0032727) | 3.20503207 |
56 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.18352650 |
57 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.16143126 |
58 | angiotensin maturation (GO:0002003) | 3.15688298 |
59 | regulation of antigen processing and presentation (GO:0002577) | 3.13019296 |
60 | response to peptidoglycan (GO:0032494) | 3.12743277 |
61 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.12029150 |
62 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.08305516 |
63 | regulation of mast cell activation (GO:0033003) | 3.06464688 |
64 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.05138654 |
65 | folic acid metabolic process (GO:0046655) | 3.04979720 |
66 | dendritic cell differentiation (GO:0097028) | 3.04253450 |
67 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.04045760 |
68 | DNA deamination (GO:0045006) | 3.03897177 |
69 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.03060104 |
70 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.02627647 |
71 | regulation of mononuclear cell migration (GO:0071675) | 3.01639118 |
72 | B cell mediated immunity (GO:0019724) | 3.01218041 |
73 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.00891772 |
74 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.00891772 |
75 | myeloid dendritic cell activation (GO:0001773) | 2.99945801 |
76 | regulation of interferon-alpha production (GO:0032647) | 2.99856673 |
77 | myeloid cell activation involved in immune response (GO:0002275) | 2.99832045 |
78 | T-helper 1 type immune response (GO:0042088) | 2.99746692 |
79 | lytic vacuole organization (GO:0080171) | 2.97871954 |
80 | lysosome organization (GO:0007040) | 2.97871954 |
81 | interferon-gamma secretion (GO:0072643) | 2.96751204 |
82 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.95724981 |
83 | base-excision repair, AP site formation (GO:0006285) | 2.94753012 |
84 | * N-acetylneuraminate metabolic process (GO:0006054) | 2.93964229 |
85 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.93611781 |
86 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.93611781 |
87 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.93611781 |
88 | detection of other organism (GO:0098543) | 2.93296028 |
89 | mitotic metaphase plate congression (GO:0007080) | 2.93236069 |
90 | intracellular pH reduction (GO:0051452) | 2.92838966 |
91 | ribosome biogenesis (GO:0042254) | 2.92756119 |
92 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.91507969 |
93 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.91507969 |
94 | regulation of gamma-delta T cell activation (GO:0046643) | 2.91404075 |
95 | positive regulation of interferon-beta production (GO:0032728) | 2.91272661 |
96 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.90387490 |
97 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.89885661 |
98 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.89885661 |
99 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.88842254 |
100 | cellular response to cadmium ion (GO:0071276) | 2.88457041 |
101 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.85271989 |
102 | glycolipid catabolic process (GO:0019377) | 2.84367578 |
103 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.84309517 |
104 | response to host immune response (GO:0052572) | 2.84309517 |
105 | rRNA modification (GO:0000154) | 2.82642154 |
106 | defense response to protozoan (GO:0042832) | 2.82002582 |
107 | response to protozoan (GO:0001562) | 2.81432332 |
108 | negative regulation of interleukin-1 production (GO:0032692) | 2.80779578 |
109 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.78889771 |
110 | detection of molecule of bacterial origin (GO:0032490) | 2.78394964 |
111 | DNA replication checkpoint (GO:0000076) | 2.78374072 |
112 | detection of bacterium (GO:0016045) | 2.77749185 |
113 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.77622508 |
114 | myeloid leukocyte activation (GO:0002274) | 2.76131149 |
115 | negative regulation of ligase activity (GO:0051352) | 2.75869380 |
116 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.75869380 |
117 | telomere maintenance via recombination (GO:0000722) | 2.73136034 |
118 | centriole replication (GO:0007099) | 2.72934281 |
119 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.71481526 |
120 | response to muramyl dipeptide (GO:0032495) | 2.70290867 |
121 | detection of external biotic stimulus (GO:0098581) | 2.69958166 |
122 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.69832047 |
123 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.69751891 |
124 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.69550720 |
125 | ceramide catabolic process (GO:0046514) | 2.67212901 |
126 | oligosaccharide catabolic process (GO:0009313) | 2.66626233 |
127 | pH reduction (GO:0045851) | 2.66593876 |
128 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.66359693 |
129 | regulation of leukocyte degranulation (GO:0043300) | 2.65905169 |
130 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.65838127 |
131 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.62774686 |
132 | macrophage activation involved in immune response (GO:0002281) | 2.62294280 |
133 | protein localization to kinetochore (GO:0034501) | 2.61940016 |
134 | regulation of translation in response to stress (GO:0043555) | 2.61314418 |
135 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.59109247 |
136 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.56752263 |
137 | positive regulation of cell cycle arrest (GO:0071158) | 2.56035177 |
138 | endosome to pigment granule transport (GO:0043485) | 2.55792088 |
139 | endosome to melanosome transport (GO:0035646) | 2.55792088 |
140 | positive regulation of ligase activity (GO:0051351) | 2.53945862 |
141 | maturation of SSU-rRNA (GO:0030490) | 2.52569272 |
142 | granulocyte activation (GO:0036230) | 2.52283695 |
143 | mitotic nuclear envelope disassembly (GO:0007077) | 2.51783227 |
144 | DNA strand elongation (GO:0022616) | 2.51509419 |
145 | regulation of interferon-beta production (GO:0032648) | 2.49591043 |
146 | neutrophil activation (GO:0042119) | 2.48657807 |
147 | cellular response to interferon-alpha (GO:0035457) | 2.48568613 |
148 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.47441924 |
149 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.47050337 |
150 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.46608432 |
151 | regulation of RIG-I signaling pathway (GO:0039535) | 2.46415820 |
152 | DNA replication initiation (GO:0006270) | 2.45426151 |
153 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.45202512 |
154 | regulation of spindle organization (GO:0090224) | 2.45021927 |
155 | cyclooxygenase pathway (GO:0019371) | 2.43681157 |
156 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.43445706 |
157 | cell cycle G1/S phase transition (GO:0044843) | 2.43445706 |
158 | blastocyst development (GO:0001824) | 2.40864103 |
159 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.40708625 |
160 | mitotic recombination (GO:0006312) | 2.40199614 |
161 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.39621811 |
162 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.38188524 |
163 | respiratory burst (GO:0045730) | 2.37855037 |
164 | pinocytosis (GO:0006907) | 2.36844014 |
165 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.36640723 |
166 | regulation of integrin activation (GO:0033623) | 2.36410197 |
167 | lymphocyte mediated immunity (GO:0002449) | 2.35285517 |
168 | superoxide anion generation (GO:0042554) | 2.34954196 |
169 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.33247877 |
170 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.32884455 |
171 | glycosphingolipid catabolic process (GO:0046479) | 2.32102543 |
172 | positive regulation of T cell apoptotic process (GO:0070234) | 2.31764051 |
173 | nuclear envelope disassembly (GO:0051081) | 2.29399888 |
174 | membrane disassembly (GO:0030397) | 2.29399888 |
175 | wound healing, spreading of epidermal cells (GO:0035313) | 2.28497469 |
176 | positive regulation of chromosome segregation (GO:0051984) | 2.28396726 |
177 | replication fork processing (GO:0031297) | 2.27288889 |
178 | ribosomal large subunit biogenesis (GO:0042273) | 2.26383214 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.06095853 |
2 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 3.36865466 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.33579641 |
4 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.02813814 |
5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.90051054 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.84023660 |
7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.79866378 |
8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.76969703 |
9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.72277271 |
10 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.71040286 |
11 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.43140863 |
12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.43083873 |
13 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.41340252 |
14 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.35923441 |
15 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.32245723 |
16 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.30711464 |
17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.29566688 |
18 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.26644237 |
19 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.22568978 |
20 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.22046535 |
21 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.21675996 |
22 | SPI1_23127762_ChIP-Seq_K562_Human | 2.20492328 |
23 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.20438554 |
24 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.20095527 |
25 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.18494893 |
26 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.14561218 |
27 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.14346689 |
28 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.11755240 |
29 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10983298 |
30 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.09533074 |
31 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.06980541 |
32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.03849812 |
33 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.02173714 |
34 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.00905666 |
35 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 2.00825343 |
36 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.88532733 |
37 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.85731169 |
38 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.84185212 |
39 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.78943451 |
40 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.76758866 |
41 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.75970047 |
42 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.75324593 |
43 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.72957057 |
44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.72617940 |
45 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.71698981 |
46 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.71148960 |
47 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.69577350 |
48 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.67575494 |
49 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.67575494 |
50 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.67575494 |
51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.67259814 |
52 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.66911203 |
53 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.63836666 |
54 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.63832406 |
55 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.62570026 |
56 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.61888318 |
57 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.60676832 |
58 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.57765701 |
59 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.57280244 |
60 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.55928017 |
61 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.54228091 |
62 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.53403343 |
63 | MAF_26560356_Chip-Seq_TH1_Human | 1.52095842 |
64 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.51329286 |
65 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.50460515 |
66 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.49774597 |
67 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.49771316 |
68 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.48495979 |
69 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.48084541 |
70 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.46525186 |
71 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.46451589 |
72 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.45062834 |
73 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.44462568 |
74 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.42682518 |
75 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41419661 |
76 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.40732965 |
77 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.40043713 |
78 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.39988270 |
79 | GATA1_19941826_ChIP-Seq_K562_Human | 1.39319381 |
80 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.38328231 |
81 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38053598 |
82 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36054831 |
83 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.36008338 |
84 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.35931380 |
85 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.35780580 |
86 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.35035444 |
87 | MAF_26560356_Chip-Seq_TH2_Human | 1.34451577 |
88 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.34238129 |
89 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.33850345 |
90 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.33600775 |
91 | MYB_26560356_Chip-Seq_TH2_Human | 1.32492511 |
92 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.32402735 |
93 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.32336110 |
94 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31794429 |
95 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.31221140 |
96 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.31133816 |
97 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.30430189 |
98 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.29795240 |
99 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.29605402 |
100 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29588738 |
101 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.29246415 |
102 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.29084099 |
103 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28841175 |
104 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28612454 |
105 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.27451851 |
106 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.27158330 |
107 | UTX_26944678_Chip-Seq_JUKART_Human | 1.21662968 |
108 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.21334906 |
109 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21330496 |
110 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.20755834 |
111 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.20389401 |
112 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.19976294 |
113 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19027687 |
114 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16030763 |
115 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15234295 |
116 | GATA3_26560356_Chip-Seq_TH2_Human | 1.14932906 |
117 | SA1_27219007_Chip-Seq_Bcells_Human | 1.14516252 |
118 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.14142795 |
119 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.12198636 |
120 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.12095483 |
121 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.11737177 |
122 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.10673867 |
123 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.09191161 |
124 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.08712111 |
125 | MYB_26560356_Chip-Seq_TH1_Human | 1.08377763 |
126 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.08254697 |
127 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.07833058 |
128 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.07668321 |
129 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.07577188 |
130 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.07413921 |
131 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.07102154 |
132 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.07033561 |
133 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.06641505 |
134 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.06061642 |
135 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.03467983 |
136 | MYC_22102868_ChIP-Seq_BL_Human | 1.03297211 |
137 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.01868858 |
138 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.01201639 |
139 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.01025879 |
140 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.00885355 |
141 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00671085 |
142 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.00496291 |
143 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.00297734 |
144 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.00277918 |
145 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.00161903 |
146 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00146123 |
147 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99680045 |
148 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.99588629 |
149 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.99193989 |
150 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.99014300 |
151 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98385436 |
152 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.98312250 |
153 | GATA1_22025678_ChIP-Seq_K562_Human | 0.98097315 |
154 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.97714854 |
155 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.97674324 |
156 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.96848014 |
157 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96116303 |
158 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.96114837 |
159 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.95866567 |
160 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.95837752 |
161 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95517210 |
162 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.95461283 |
163 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.94986407 |
164 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.93024638 |
165 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92703022 |
166 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92219215 |
167 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.91119658 |
168 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.90289385 |
169 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.87315208 |
170 | P68_20966046_ChIP-Seq_HELA_Human | 0.86503612 |
171 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.85896788 |
172 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.85311591 |
173 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.84550862 |
174 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.83963561 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005083_abnormal_biliary_tract | 4.01297304 |
2 | MP0005058_abnormal_lysosome_morphology | 3.47188899 |
3 | MP0003693_abnormal_embryo_hatching | 3.40864797 |
4 | MP0001835_abnormal_antigen_presentation | 2.84478293 |
5 | MP0009840_abnormal_foam_cell | 2.79723760 |
6 | MP0003111_abnormal_nucleus_morphology | 2.57322039 |
7 | MP0005365_abnormal_bile_salt | 2.51592895 |
8 | MP0004957_abnormal_blastocyst_morpholog | 2.43962473 |
9 | MP0003436_decreased_susceptibility_to | 2.43189621 |
10 | MP0002148_abnormal_hypersensitivity_rea | 2.18618359 |
11 | MP0006082_CNS_inflammation | 2.17005635 |
12 | MP0005167_abnormal_blood-brain_barrier | 2.14836077 |
13 | MP0003077_abnormal_cell_cycle | 2.14644738 |
14 | MP0010352_gastrointestinal_tract_polyps | 2.12002015 |
15 | MP0010094_abnormal_chromosome_stability | 2.03375670 |
16 | MP0000604_amyloidosis | 2.01250161 |
17 | MP0003172_abnormal_lysosome_physiology | 2.01024598 |
18 | MP0009785_altered_susceptibility_to | 1.98162998 |
19 | MP0002419_abnormal_innate_immunity | 1.94647714 |
20 | MP0002254_reproductive_system_inflammat | 1.93600484 |
21 | MP0008057_abnormal_DNA_replication | 1.90754404 |
22 | MP0010307_abnormal_tumor_latency | 1.88636678 |
23 | MP0003186_abnormal_redox_activity | 1.83842979 |
24 | MP0005000_abnormal_immune_tolerance | 1.78454339 |
25 | MP0008260_abnormal_autophagy | 1.71400628 |
26 | MP0005025_abnormal_response_to | 1.69822031 |
27 | MP0003448_altered_tumor_morphology | 1.69762889 |
28 | MP0005397_hematopoietic_system_phenotyp | 1.68294573 |
29 | MP0001545_abnormal_hematopoietic_system | 1.68294573 |
30 | MP0002452_abnormal_antigen_presenting | 1.68201927 |
31 | MP0009278_abnormal_bone_marrow | 1.66605049 |
32 | MP0001853_heart_inflammation | 1.62564868 |
33 | MP0003300_gastrointestinal_ulcer | 1.62446441 |
34 | MP0003718_maternal_effect | 1.62221428 |
35 | MP0008007_abnormal_cellular_replicative | 1.60190292 |
36 | MP0003566_abnormal_cell_adhesion | 1.59581898 |
37 | MP0009333_abnormal_splenocyte_physiolog | 1.55603511 |
38 | MP0008961_abnormal_basal_metabolism | 1.54261051 |
39 | MP0008058_abnormal_DNA_repair | 1.52135930 |
40 | MP0003690_abnormal_glial_cell | 1.49921214 |
41 | MP0003075_altered_response_to | 1.49576768 |
42 | MP0003786_premature_aging | 1.46500921 |
43 | MP0000685_abnormal_immune_system | 1.45232487 |
44 | MP0002723_abnormal_immune_serum | 1.44343248 |
45 | MP0003191_abnormal_cellular_cholesterol | 1.42104574 |
46 | MP0005670_abnormal_white_adipose | 1.36491622 |
47 | MP0001800_abnormal_humoral_immune | 1.36489578 |
48 | MP0004043_abnormal_pH_regulation | 1.36262551 |
49 | MP0002139_abnormal_hepatobiliary_system | 1.36038833 |
50 | MP0008932_abnormal_embryonic_tissue | 1.35685126 |
51 | MP0000858_altered_metastatic_potential | 1.35262839 |
52 | MP0002405_respiratory_system_inflammati | 1.34834363 |
53 | MP0005085_abnormal_gallbladder_physiolo | 1.34052811 |
54 | MP0001819_abnormal_immune_cell | 1.33323430 |
55 | MP0003303_peritoneal_inflammation | 1.31742901 |
56 | MP0000343_altered_response_to | 1.31473715 |
57 | MP0002998_abnormal_bone_remodeling | 1.30335085 |
58 | MP0002420_abnormal_adaptive_immunity | 1.29674858 |
59 | MP0000490_abnormal_crypts_of | 1.28041792 |
60 | MP0005671_abnormal_response_to | 1.27825767 |
61 | MP0000015_abnormal_ear_pigmentation | 1.26882346 |
62 | MP0005387_immune_system_phenotype | 1.26826108 |
63 | MP0001790_abnormal_immune_system | 1.26826108 |
64 | MP0001533_abnormal_skeleton_physiology | 1.26617332 |
65 | MP0005023_abnormal_wound_healing | 1.25985616 |
66 | MP0002396_abnormal_hematopoietic_system | 1.24000632 |
67 | MP0003195_calcinosis | 1.23584268 |
68 | MP0004782_abnormal_surfactant_physiolog | 1.23177371 |
69 | MP0000371_diluted_coat_color | 1.22565755 |
70 | MP0003252_abnormal_bile_duct | 1.21617891 |
71 | MP0005451_abnormal_body_composition | 1.19610714 |
72 | MP0005464_abnormal_platelet_physiology | 1.19475621 |
73 | MP0003705_abnormal_hypodermis_morpholog | 1.19450841 |
74 | MP0003724_increased_susceptibility_to | 1.17059375 |
75 | MP0000350_abnormal_cell_proliferation | 1.15908702 |
76 | MP0000689_abnormal_spleen_morphology | 1.15426801 |
77 | MP0001845_abnormal_inflammatory_respons | 1.13464339 |
78 | MP0001730_embryonic_growth_arrest | 1.12565341 |
79 | MP0008438_abnormal_cutaneous_collagen | 1.11905093 |
80 | MP0001542_abnormal_bone_strength | 1.09753511 |
81 | MP0002722_abnormal_immune_system | 1.08838478 |
82 | MP0005076_abnormal_cell_differentiation | 1.08791818 |
83 | MP0008469_abnormal_protein_level | 1.06493940 |
84 | MP0000716_abnormal_immune_system | 1.06203420 |
85 | MP0005257_abnormal_intraocular_pressure | 1.03857059 |
86 | MP0000313_abnormal_cell_death | 1.03506661 |
87 | MP0002398_abnormal_bone_marrow | 1.03161293 |
88 | MP0004947_skin_inflammation | 1.01614524 |
89 | MP0002837_dystrophic_cardiac_calcinosis | 1.00538118 |
90 | MP0002429_abnormal_blood_cell | 1.00467053 |
91 | MP0003828_pulmonary_edema | 1.00037857 |
92 | MP0002138_abnormal_hepatobiliary_system | 0.99711243 |
93 | MP0004510_myositis | 0.99654320 |
94 | MP0003806_abnormal_nucleotide_metabolis | 0.99310295 |
95 | MP0002019_abnormal_tumor_incidence | 0.97815297 |
96 | MP0003183_abnormal_peptide_metabolism | 0.95946929 |
97 | MP0001958_emphysema | 0.94207614 |
98 | MP0005380_embryogenesis_phenotype | 0.94119196 |
99 | MP0001672_abnormal_embryogenesis/_devel | 0.94119196 |
100 | MP0002277_abnormal_respiratory_mucosa | 0.92924146 |
101 | MP0001663_abnormal_digestive_system | 0.92405650 |
102 | MP0003941_abnormal_skin_development | 0.90878982 |
103 | MP0010155_abnormal_intestine_physiology | 0.90258531 |
104 | MP0010329_abnormal_lipoprotein_level | 0.89079671 |
105 | MP0000465_gastrointestinal_hemorrhage | 0.88448399 |
106 | MP0002086_abnormal_extraembryonic_tissu | 0.88308169 |
107 | MP0005395_other_phenotype | 0.88198005 |
108 | MP0009115_abnormal_fat_cell | 0.87596783 |
109 | MP0005174_abnormal_tail_pigmentation | 0.87404255 |
110 | MP0000372_irregular_coat_pigmentation | 0.87100175 |
111 | MP0009764_decreased_sensitivity_to | 0.86282109 |
112 | MP0003329_amyloid_beta_deposits | 0.86026719 |
113 | MP0004808_abnormal_hematopoietic_stem | 0.85739028 |
114 | MP0002088_abnormal_embryonic_growth/wei | 0.85023289 |
115 | MP0003984_embryonic_growth_retardation | 0.84767308 |
116 | MP0005310_abnormal_salivary_gland | 0.84638185 |
117 | MP0000920_abnormal_myelination | 0.83724470 |
118 | MP0004019_abnormal_vitamin_homeostasis | 0.82840884 |
119 | MP0005075_abnormal_melanosome_morpholog | 0.81945328 |
120 | MP0003567_abnormal_fetal_cardiomyocyte | 0.81440072 |
121 | MP0002136_abnormal_kidney_physiology | 0.80329580 |
122 | MP0005390_skeleton_phenotype | 0.80280567 |
123 | MP0002080_prenatal_lethality | 0.79866188 |
124 | MP0001697_abnormal_embryo_size | 0.79831139 |
125 | MP0000358_abnormal_cell_content/ | 0.79474222 |
126 | MP0009763_increased_sensitivity_to | 0.79294027 |
127 | MP0005621_abnormal_cell_physiology | 0.78090217 |
128 | MP0000627_abnormal_mammary_gland | 0.77659960 |
129 | MP0001756_abnormal_urination | 0.77483841 |
130 | MP0005166_decreased_susceptibility_to | 0.76631356 |
131 | MP0003453_abnormal_keratinocyte_physiol | 0.76025532 |
132 | MP0004381_abnormal_hair_follicle | 0.74068000 |
133 | MP0009765_abnormal_xenobiotic_induced | 0.71574977 |
134 | MP0005171_absent_coat_pigmentation | 0.71297224 |
135 | MP0001501_abnormal_sleep_pattern | 0.70664652 |
136 | MP0005334_abnormal_fat_pad | 0.68355530 |
137 | MP0005164_abnormal_response_to | 0.67427971 |
138 | MP0001873_stomach_inflammation | 0.65779578 |
139 | MP0002933_joint_inflammation | 0.65434646 |
140 | MP0002877_abnormal_melanocyte_morpholog | 0.65269525 |
141 | MP0003763_abnormal_thymus_physiology | 0.65088770 |
142 | MP0002118_abnormal_lipid_homeostasis | 0.64894833 |
143 | MP0002095_abnormal_skin_pigmentation | 0.63029939 |
144 | MP0004742_abnormal_vestibular_system | 0.62773908 |
145 | MP0008874_decreased_physiological_sensi | 0.60609544 |
146 | MP0003656_abnormal_erythrocyte_physiolo | 0.60259433 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 4.72838080 |
2 | Vacuolated lymphocytes (HP:0001922) | 4.53380801 |
3 | Abnormality of macrophages (HP:0004311) | 4.46536122 |
4 | Loss of speech (HP:0002371) | 4.26373399 |
5 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.20751305 |
6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.20751305 |
7 | Abnormality of glycolipid metabolism (HP:0010969) | 4.20751305 |
8 | Eczematoid dermatitis (HP:0000976) | 4.16655845 |
9 | Recurrent bacterial skin infections (HP:0005406) | 4.11875993 |
10 | Agnosia (HP:0010524) | 3.79043710 |
11 | Increased cerebral lipofuscin (HP:0011813) | 3.70325818 |
12 | Mutism (HP:0002300) | 3.68461165 |
13 | Stomatitis (HP:0010280) | 3.56292062 |
14 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.35900145 |
15 | Poor head control (HP:0002421) | 3.27184002 |
16 | Breast hypoplasia (HP:0003187) | 3.21238669 |
17 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.17379059 |
18 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.17379059 |
19 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.17379059 |
20 | Optic neuritis (HP:0100653) | 3.16109574 |
21 | Retrobulbar optic neuritis (HP:0100654) | 3.16109574 |
22 | Pustule (HP:0200039) | 3.11730539 |
23 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.09347167 |
24 | Prolonged neonatal jaundice (HP:0006579) | 3.07248712 |
25 | Spinal muscular atrophy (HP:0007269) | 3.07222047 |
26 | Autoimmune thrombocytopenia (HP:0001973) | 3.05443467 |
27 | Abnormality of the prostate (HP:0008775) | 3.01165407 |
28 | Multiple enchondromatosis (HP:0005701) | 2.98599731 |
29 | Birth length less than 3rd percentile (HP:0003561) | 2.97502523 |
30 | Pulmonary infiltrates (HP:0002113) | 2.95302159 |
31 | Carpal bone hypoplasia (HP:0001498) | 2.90002873 |
32 | Hemoptysis (HP:0002105) | 2.89156632 |
33 | Inappropriate behavior (HP:0000719) | 2.87190518 |
34 | Degeneration of anterior horn cells (HP:0002398) | 2.86770247 |
35 | Abnormality of the anterior horn cell (HP:0006802) | 2.86770247 |
36 | Personality changes (HP:0000751) | 2.82307381 |
37 | Rough bone trabeculation (HP:0100670) | 2.77689775 |
38 | Retinal atrophy (HP:0001105) | 2.75690815 |
39 | Meningitis (HP:0001287) | 2.72076546 |
40 | Purpura (HP:0000979) | 2.64914475 |
41 | Systemic lupus erythematosus (HP:0002725) | 2.64757354 |
42 | Obstructive lung disease (HP:0006536) | 2.63645116 |
43 | Chronic obstructive pulmonary disease (HP:0006510) | 2.63645116 |
44 | Petechiae (HP:0000967) | 2.61460461 |
45 | Mediastinal lymphadenopathy (HP:0100721) | 2.60323794 |
46 | Axonal loss (HP:0003447) | 2.58289065 |
47 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.54945182 |
48 | Osteolytic defects of the hand bones (HP:0009699) | 2.54945182 |
49 | Vertebral compression fractures (HP:0002953) | 2.54022360 |
50 | Hematochezia (HP:0002573) | 2.53649772 |
51 | Tongue fasciculations (HP:0001308) | 2.51892909 |
52 | Dysostosis multiplex (HP:0000943) | 2.51591437 |
53 | Spontaneous hematomas (HP:0007420) | 2.51193534 |
54 | Nausea (HP:0002018) | 2.50466500 |
55 | Basal ganglia calcification (HP:0002135) | 2.49323551 |
56 | Glomerulonephritis (HP:0000099) | 2.47588948 |
57 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.46166846 |
58 | Neurofibrillary tangles (HP:0002185) | 2.45690601 |
59 | Polyneuropathy (HP:0001271) | 2.44323492 |
60 | Hepatosplenomegaly (HP:0001433) | 2.38761240 |
61 | Chest pain (HP:0100749) | 2.36938907 |
62 | Gingivitis (HP:0000230) | 2.36937730 |
63 | Abnormality of the umbilical cord (HP:0010881) | 2.35921915 |
64 | Vasculitis (HP:0002633) | 2.34762645 |
65 | Recurrent cutaneous fungal infections (HP:0011370) | 2.34566399 |
66 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.34566399 |
67 | Abnormal trabecular bone morphology (HP:0100671) | 2.34212660 |
68 | Interstitial pulmonary disease (HP:0006530) | 2.33763442 |
69 | Nuclear cataract (HP:0100018) | 2.32004953 |
70 | Increased IgM level (HP:0003496) | 2.30010113 |
71 | Mesangial abnormality (HP:0001966) | 2.29966413 |
72 | Prostate neoplasm (HP:0100787) | 2.26500691 |
73 | Muscle fibrillation (HP:0010546) | 2.26384254 |
74 | Progressive neurologic deterioration (HP:0002344) | 2.24224590 |
75 | Recurrent fungal infections (HP:0002841) | 2.22428501 |
76 | Global brain atrophy (HP:0002283) | 2.21578268 |
77 | Cheilitis (HP:0100825) | 2.21155901 |
78 | Pulmonary embolism (HP:0002204) | 2.19495137 |
79 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.19338805 |
80 | Urticaria (HP:0001025) | 2.19226872 |
81 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.18865426 |
82 | Encephalitis (HP:0002383) | 2.15825820 |
83 | Recurrent skin infections (HP:0001581) | 2.15163394 |
84 | Reticulocytopenia (HP:0001896) | 2.14363236 |
85 | Increased serum ferritin (HP:0003281) | 2.14297938 |
86 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.13388387 |
87 | Gangrene (HP:0100758) | 2.12635471 |
88 | Cervical subluxation (HP:0003308) | 2.11444494 |
89 | Diminished motivation (HP:0000745) | 2.11287724 |
90 | Disinhibition (HP:0000734) | 2.09682821 |
91 | Amyloidosis (HP:0011034) | 2.08580595 |
92 | Upper motor neuron abnormality (HP:0002127) | 2.08535998 |
93 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.07575490 |
94 | Trismus (HP:0000211) | 2.05982436 |
95 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.05033905 |
96 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.04696980 |
97 | Pathologic fracture (HP:0002756) | 2.03947078 |
98 | Abnormality of the pleura (HP:0002103) | 2.03838527 |
99 | Restrictive lung disease (HP:0002091) | 2.02057158 |
100 | Patellar aplasia (HP:0006443) | 1.99882654 |
101 | Fused cervical vertebrae (HP:0002949) | 1.97774700 |
102 | Apathy (HP:0000741) | 1.97217992 |
103 | Absent radius (HP:0003974) | 1.97127191 |
104 | Cutaneous photosensitivity (HP:0000992) | 1.96283136 |
105 | Keratoconjunctivitis sicca (HP:0001097) | 1.96245062 |
106 | Sparse eyelashes (HP:0000653) | 1.96202513 |
107 | Neuronal loss in central nervous system (HP:0002529) | 1.95868444 |
108 | Bone marrow hypocellularity (HP:0005528) | 1.94396242 |
109 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.91633665 |
110 | Tetraparesis (HP:0002273) | 1.91449949 |
111 | Keratoconjunctivitis (HP:0001096) | 1.91392024 |
112 | Clumsiness (HP:0002312) | 1.91219910 |
113 | Pulmonary fibrosis (HP:0002206) | 1.91182076 |
114 | Chromsome breakage (HP:0040012) | 1.90963391 |
115 | Complement deficiency (HP:0004431) | 1.90768079 |
116 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.90748456 |
117 | Cleft eyelid (HP:0000625) | 1.90506046 |
118 | Granulocytopenia (HP:0001913) | 1.90369860 |
119 | Premature loss of primary teeth (HP:0006323) | 1.89509036 |
120 | Epistaxis (HP:0000421) | 1.88907386 |
121 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.88869240 |
122 | Porencephaly (HP:0002132) | 1.88487934 |
123 | Premature rupture of membranes (HP:0001788) | 1.88407173 |
124 | Tubulointerstitial fibrosis (HP:0005576) | 1.86963686 |
125 | Meckel diverticulum (HP:0002245) | 1.86238670 |
126 | Ocular albinism (HP:0001107) | 1.85028031 |
127 | Ureteral duplication (HP:0000073) | 1.84890554 |
128 | Anorexia (HP:0002039) | 1.84007261 |
129 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.83910682 |
130 | Mucopolysacchariduria (HP:0008155) | 1.83910682 |
131 | Dementia (HP:0000726) | 1.83560399 |
132 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.83411635 |
133 | Abnormality of iron homeostasis (HP:0011031) | 1.83165405 |
134 | Episodic fever (HP:0001954) | 1.83135991 |
135 | Myositis (HP:0100614) | 1.82335358 |
136 | Selective tooth agenesis (HP:0001592) | 1.81410125 |
137 | Abnormality of the ileum (HP:0001549) | 1.80436006 |
138 | Premature ovarian failure (HP:0008209) | 1.79880034 |
139 | Albinism (HP:0001022) | 1.79666312 |
140 | Increased CSF protein (HP:0002922) | 1.78849003 |
141 | Aplasia involving forearm bones (HP:0009822) | 1.76036374 |
142 | Absent forearm bone (HP:0003953) | 1.76036374 |
143 | Myocardial infarction (HP:0001658) | 1.75031285 |
144 | Arterial thrombosis (HP:0004420) | 1.74851754 |
145 | Leukocytosis (HP:0001974) | 1.74658301 |
146 | Eosinophilia (HP:0001880) | 1.73893163 |
147 | Hypokinesia (HP:0002375) | 1.73581644 |
148 | Rectovaginal fistula (HP:0000143) | 1.73016484 |
149 | Rectal fistula (HP:0100590) | 1.73016484 |
150 | Peripheral demyelination (HP:0011096) | 1.72466450 |
151 | Psychosis (HP:0000709) | 1.70991140 |
152 | Orchitis (HP:0100796) | 1.70904368 |
153 | Leukopenia (HP:0001882) | 1.70645005 |
154 | Absent hand (HP:0004050) | 1.70447485 |
155 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.70404994 |
156 | Patent foramen ovale (HP:0001655) | 1.68702676 |
157 | Periodontitis (HP:0000704) | 1.68623580 |
158 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.68335955 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CCNB1 | 4.72929053 |
2 | CAMKK2 | 4.24536260 |
3 | BUB1 | 3.96972783 |
4 | WEE1 | 3.93225271 |
5 | CAMK1D | 3.57333234 |
6 | EPHA2 | 3.52019984 |
7 | IRAK3 | 3.24601898 |
8 | PIM2 | 2.73405333 |
9 | PBK | 2.57211544 |
10 | NME2 | 2.47369077 |
11 | BLK | 2.18882227 |
12 | TXK | 2.13679496 |
13 | EIF2AK1 | 2.12799129 |
14 | PLK4 | 2.11766776 |
15 | CAMK1G | 2.07706825 |
16 | ZAK | 1.95866597 |
17 | IKBKB | 1.92831751 |
18 | MAP3K14 | 1.82747033 |
19 | TBK1 | 1.82469414 |
20 | IRAK4 | 1.78243857 |
21 | GRK7 | 1.60270296 |
22 | NEK2 | 1.59365825 |
23 | FGR | 1.58148394 |
24 | TYK2 | 1.58043379 |
25 | FES | 1.57316199 |
26 | CAMKK1 | 1.56226771 |
27 | SYK | 1.55874503 |
28 | AKT3 | 1.52602040 |
29 | TSSK6 | 1.51553860 |
30 | PIM1 | 1.50120406 |
31 | NEK1 | 1.49318895 |
32 | TTK | 1.46461813 |
33 | TNK2 | 1.45561217 |
34 | ADRBK2 | 1.45003717 |
35 | SMG1 | 1.40563182 |
36 | MST1R | 1.36134502 |
37 | SRPK1 | 1.34699531 |
38 | EIF2AK3 | 1.33342786 |
39 | RPS6KA4 | 1.32546381 |
40 | STK4 | 1.29458025 |
41 | ABL2 | 1.29239087 |
42 | ARAF | 1.28959973 |
43 | MAP3K11 | 1.28916131 |
44 | PAK4 | 1.27318872 |
45 | TAF1 | 1.27274735 |
46 | PLK1 | 1.26788858 |
47 | PRPF4B | 1.18478551 |
48 | TAOK2 | 1.16572972 |
49 | TESK2 | 1.12863503 |
50 | MAP3K3 | 1.11675822 |
51 | KIT | 1.10375409 |
52 | STK10 | 1.09824648 |
53 | TAOK1 | 1.08421340 |
54 | STK3 | 1.05759306 |
55 | PDK2 | 1.05355286 |
56 | CDK7 | 1.05081941 |
57 | VRK2 | 1.04698092 |
58 | CHUK | 1.04398360 |
59 | MAP3K8 | 1.04215145 |
60 | RPS6KB2 | 1.03912473 |
61 | EIF2AK2 | 1.03107550 |
62 | RIPK4 | 1.02620154 |
63 | ACVR1B | 1.02572120 |
64 | BRSK2 | 1.01203575 |
65 | NEK9 | 1.01167361 |
66 | STK16 | 0.94037650 |
67 | MATK | 0.92923132 |
68 | CDK12 | 0.91925295 |
69 | DAPK2 | 0.91628733 |
70 | MAP4K1 | 0.88979016 |
71 | BMX | 0.87231534 |
72 | MARK2 | 0.83723536 |
73 | ERN1 | 0.83463542 |
74 | BTK | 0.82459455 |
75 | IKBKE | 0.80520059 |
76 | KDR | 0.80438164 |
77 | MAP3K7 | 0.79966202 |
78 | MST4 | 0.79540734 |
79 | AURKB | 0.79439925 |
80 | LCK | 0.79217363 |
81 | ATR | 0.78858067 |
82 | ZAP70 | 0.76936897 |
83 | MAP2K3 | 0.76804064 |
84 | STK24 | 0.75338138 |
85 | DYRK3 | 0.75240244 |
86 | CAMK1 | 0.74988694 |
87 | PAK1 | 0.74792356 |
88 | WNK4 | 0.74566790 |
89 | TGFBR2 | 0.73838943 |
90 | PLK3 | 0.73133886 |
91 | TAOK3 | 0.73112466 |
92 | CHEK2 | 0.70477450 |
93 | AURKA | 0.68291526 |
94 | TESK1 | 0.67774891 |
95 | JAK3 | 0.67526299 |
96 | CSF1R | 0.66792501 |
97 | LRRK2 | 0.66502397 |
98 | CDK4 | 0.66092829 |
99 | HIPK2 | 0.65674592 |
100 | CDC42BPA | 0.64907511 |
101 | VRK1 | 0.64768652 |
102 | ALK | 0.63395423 |
103 | CDC7 | 0.61104066 |
104 | CSK | 0.60997470 |
105 | MAPK4 | 0.60974103 |
106 | TGFBR1 | 0.57698246 |
107 | LYN | 0.57196412 |
108 | MET | 0.56455887 |
109 | MAP2K6 | 0.56263369 |
110 | JAK2 | 0.55176796 |
111 | ITK | 0.53652984 |
112 | DDR2 | 0.52358970 |
113 | CSNK2A1 | 0.51190654 |
114 | MARK3 | 0.51078308 |
115 | PRKCD | 0.50546706 |
116 | MKNK1 | 0.49587547 |
117 | CAMK4 | 0.49327396 |
118 | HCK | 0.48290945 |
119 | TRPM7 | 0.48198260 |
120 | TLK1 | 0.48156906 |
121 | STK38L | 0.48068521 |
122 | MAP3K5 | 0.47537199 |
123 | MAP3K1 | 0.46937753 |
124 | CDK6 | 0.45835525 |
125 | GRK6 | 0.45559825 |
126 | PRKCI | 0.44074703 |
127 | PRKAA2 | 0.43604872 |
128 | RPS6KA5 | 0.43179942 |
129 | YES1 | 0.42756018 |
130 | BRAF | 0.41150990 |
131 | MOS | 0.40887803 |
132 | TEC | 0.40729354 |
133 | CHEK1 | 0.39360748 |
134 | RPS6KA6 | 0.38567928 |
135 | JAK1 | 0.37911403 |
136 | ABL1 | 0.37321746 |
137 | DYRK1B | 0.37103081 |
138 | ERBB3 | 0.36365228 |
139 | PNCK | 0.35729872 |
140 | NUAK1 | 0.35671046 |
141 | MAP3K13 | 0.35435681 |
142 | IRAK2 | 0.35095058 |
143 | RPS6KL1 | 0.34667628 |
144 | RPS6KC1 | 0.34667628 |
145 | CSNK1G3 | 0.34104091 |
146 | PDPK1 | 0.33771794 |
147 | SIK2 | 0.29062512 |
148 | PDK1 | 0.28895011 |
149 | IRAK1 | 0.28704239 |
150 | CSNK1G2 | 0.27022345 |
151 | PRKCQ | 0.26746796 |
152 | BCKDK | 0.26157645 |
153 | PRKD2 | 0.25912825 |
154 | GRK1 | 0.24383424 |
155 | GRK5 | 0.23205786 |
156 | PKN1 | 0.22870604 |
157 | FYN | 0.21056696 |
158 | MAPK12 | 0.20930889 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proteasome_Homo sapiens_hsa03050 | 3.98266447 |
2 | DNA replication_Homo sapiens_hsa03030 | 2.84570030 |
3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.68771132 |
4 | Mismatch repair_Homo sapiens_hsa03430 | 2.42140230 |
5 | RNA polymerase_Homo sapiens_hsa03020 | 2.40784372 |
6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.40567244 |
7 | Lysosome_Homo sapiens_hsa04142 | 2.22829739 |
8 | Base excision repair_Homo sapiens_hsa03410 | 2.08759527 |
9 | Ribosome_Homo sapiens_hsa03010 | 2.02069164 |
10 | Other glycan degradation_Homo sapiens_hsa00511 | 1.98087602 |
11 | RNA transport_Homo sapiens_hsa03013 | 1.93141463 |
12 | * Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.89667573 |
13 | Homologous recombination_Homo sapiens_hsa03440 | 1.89662983 |
14 | Legionellosis_Homo sapiens_hsa05134 | 1.79575139 |
15 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.68299239 |
16 | Spliceosome_Homo sapiens_hsa03040 | 1.60907053 |
17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.60738661 |
18 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.60107749 |
19 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.59018733 |
20 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.57938182 |
21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.49141958 |
22 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.48972292 |
23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.47653778 |
24 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.45527603 |
25 | Cell cycle_Homo sapiens_hsa04110 | 1.40571156 |
26 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.39560428 |
27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.36018994 |
28 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.33234482 |
29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.30199728 |
30 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.27610835 |
31 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.25642593 |
32 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.25377554 |
33 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.23651048 |
34 | Allograft rejection_Homo sapiens_hsa05330 | 1.23137497 |
35 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.22467687 |
36 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.21724043 |
37 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.20640111 |
38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.18501695 |
39 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.17956388 |
40 | Measles_Homo sapiens_hsa05162 | 1.16339905 |
41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.16291009 |
42 | Apoptosis_Homo sapiens_hsa04210 | 1.16229410 |
43 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.14725925 |
44 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.13037526 |
45 | Phagosome_Homo sapiens_hsa04145 | 1.12201353 |
46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.09998288 |
47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.09267713 |
48 | Tuberculosis_Homo sapiens_hsa05152 | 1.08627489 |
49 | Shigellosis_Homo sapiens_hsa05131 | 1.06726451 |
50 | Malaria_Homo sapiens_hsa05144 | 1.04798400 |
51 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.02379975 |
52 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.00373225 |
53 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.99004717 |
54 | Influenza A_Homo sapiens_hsa05164 | 0.98055598 |
55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.97237487 |
56 | Pertussis_Homo sapiens_hsa05133 | 0.97071792 |
57 | Asthma_Homo sapiens_hsa05310 | 0.92115224 |
58 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.92103118 |
59 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.91007026 |
60 | Galactose metabolism_Homo sapiens_hsa00052 | 0.89964176 |
61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.87099770 |
62 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.85215314 |
63 | Basal transcription factors_Homo sapiens_hsa03022 | 0.84913800 |
64 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.84643409 |
65 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81541567 |
66 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.77744427 |
67 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.75751760 |
68 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.74174227 |
69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.73571120 |
70 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.73231664 |
71 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.72991776 |
72 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.72746686 |
73 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72300547 |
74 | Salmonella infection_Homo sapiens_hsa05132 | 0.71663221 |
75 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.70499331 |
76 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.70419939 |
77 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.69516658 |
78 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.67331825 |
79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.66259465 |
80 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.66130095 |
81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.65804228 |
82 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.65520212 |
83 | Purine metabolism_Homo sapiens_hsa00230 | 0.64818944 |
84 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.64287666 |
85 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.63077302 |
86 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.63019306 |
87 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.59648329 |
88 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.59273128 |
89 | RNA degradation_Homo sapiens_hsa03018 | 0.58501550 |
90 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.55245258 |
91 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.53273730 |
92 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.52987196 |
93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52501606 |
94 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.51990125 |
95 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51869438 |
96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51457996 |
97 | Prion diseases_Homo sapiens_hsa05020 | 0.50495939 |
98 | Hepatitis B_Homo sapiens_hsa05161 | 0.50199004 |
99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50157521 |
100 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.49441728 |
101 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.48277849 |
102 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.47030575 |
103 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.46858233 |
104 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.46832641 |
105 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.45665388 |
106 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45537927 |
107 | Mineral absorption_Homo sapiens_hsa04978 | 0.45420677 |
108 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.44558343 |
109 | Viral myocarditis_Homo sapiens_hsa05416 | 0.44543353 |
110 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.41789164 |
111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40978619 |
112 | Platelet activation_Homo sapiens_hsa04611 | 0.40587355 |
113 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.40215328 |
114 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.39543672 |
115 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.39536311 |
116 | Amoebiasis_Homo sapiens_hsa05146 | 0.39451980 |
117 | Bladder cancer_Homo sapiens_hsa05219 | 0.39327006 |
118 | Hepatitis C_Homo sapiens_hsa05160 | 0.36563594 |
119 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.36325627 |
120 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.35974681 |
121 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.35309579 |
122 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.34788330 |
123 | Phototransduction_Homo sapiens_hsa04744 | 0.34521566 |
124 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.34030441 |
125 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.32947098 |
126 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.32361392 |
127 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.30599870 |
128 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.29618450 |
129 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.29590323 |
130 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.28368391 |
131 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26460655 |
132 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.25061270 |
133 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.24519701 |
134 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.20729288 |
135 | Endocytosis_Homo sapiens_hsa04144 | 0.19080839 |
136 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.18909966 |
137 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.17453036 |
138 | Histidine metabolism_Homo sapiens_hsa00340 | 0.15907962 |
139 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.15608713 |
140 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.15545344 |